Royalty Pharma RPRX
NASDAQ RPRX
$57.16 -0.47 (-0.82%)
At close: Oct 2, 2026 · 4:00 PM EDT

Royalty Pharma (RPRX) Selling, General & Administrative (2019 - 2026)

Updated

Royalty Pharma (RPRX) reported Selling, General & Administrative of $161.89 million for Q2 2026, down 9.9% from $179.77 million a year earlier but up 1.5% from the prior quarter.

Analysis

Royalty Pharma (RPRX) Selling, General & Administrative (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Royalty Pharma's Selling, General & Administrative came in at $604.38 million, up 45.7% year-over-year; for FY2025, it was $573.48 million, up 142.3% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 25.8% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $236.67 million in FY2024 (-5.2%), $249.75 million in FY2023 (+9.9%), $227.3 million in FY2022 (+24.3%) and $182.83 million in FY2021 (+0.6%).
  • Five-year quarterly Selling, General & Administrative spans a low of $46.16 million in Q4 2021 and a high of $179.77 million in Q2 2025.
  • Year over year, Selling, General & Administrative gained in six of the last eight quarters, with growth averaging 77.6%.
  • The high point for year-over-year Selling, General & Administrative in five years was Q2 2025 (growth of 228.6%); the low point was Q1 2024 (a decline of 32.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $159.49 million (Q1 2026), $164.27 million (Q4 2025) and $118.73 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Rocket Companies 44.95 Bn 30.63 Bn - 568.00 Mn
2 Orix 41.97 Bn 42.47 Bn - 1.24 Bn
3 Royalty Pharma 33.14 Bn 33.05 Bn - 161.89 Mn
4 Federal National Mortgage Association Fannie Mae 24.99 Bn 24.99 Bn - -
5 Affirm Holdings 23.75 Bn 17.44 Bn - 146.84 Mn
6 Synchrony Financial 23.25 Bn -44.72 Bn - -
7 Royal Gold 19.67 Bn 18.90 Bn 390.45 Mn 13.45 Mn
8 Annaly Capital Management 14.04 Bn 5.13 Bn - 58.19 Mn
9 Ares Capital 13.76 Bn 11.19 Bn - -
10 Federal Home Loan Mortgage 12.58 Bn -6.16 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 161.89 Mn
Mar 31, 2026 159.49 Mn
Dec 31, 2025 164.27 Mn
Sep 30, 2025 118.73 Mn
Jun 30, 2025 179.77 Mn
Mar 31, 2025 110.71 Mn
Dec 31, 2024 67.59 Mn
Sep 30, 2024 56.72 Mn
Jun 30, 2024 54.71 Mn
Mar 31, 2024 57.65 Mn
Dec 31, 2023 59.19 Mn
Sep 30, 2023 57.23 Mn
Jun 30, 2023 47.63 Mn
Mar 31, 2023 85.70 Mn
Dec 31, 2022 73.23 Mn
Sep 30, 2022 50.69 Mn
Jun 30, 2022 51.84 Mn
Mar 31, 2022 51.54 Mn
Dec 31, 2021 46.16 Mn
Sep 30, 2021 48.59 Mn
API Access

Royalty Pharma Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RPRX&period=max&api_key=YOUR_API_KEY